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Abstract: The tropane and granatane alkaloids belong to the larger pyrroline and piperidine classes
of plant alkaloids, respectively. Their core structures share common moieties and their scattered
distribution among angiosperms suggest that their biosynthesis may share common ancestry in some
orders, while they may be independently derived in others. Tropane and granatane alkaloid diversity
arises from the myriad modifications occurring to their core ring structures. Throughout much of
human history, humans have cultivated tropane- and granatane-producing plants for their medicinal
properties. This manuscript will discuss the diversity of their biological and ecological roles as
well as what is known about the structural genes and enzymes responsible for their biosynthesis.
In addition, modern approaches to producing some pharmaceutically important tropanes via
metabolic engineering endeavors are discussed.
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1. Introduction
Plants are sessile organisms and thus evolved natural products or “specialized metabolites” as
a chemical response to both biotic and abiotic forces. Specialized metabolites are used by plants
to defend themselves and communicate with other plants and organisms in their environments.
Whilst the chemical diversity of plant specialized metabolites is vast, with total numbers thought to
exceed over 200,000 structures, common themes of structure and function are the result of repeated
and convergent evolution of both their biosynthesis and biological roles [1]. Moreover, the chemical
structures and underlying biosynthetic enzymes of specialized metabolites serve as inspiration to
medicinal and natural product chemists.
Many specialized metabolites are pharmacologically active and have been used by humans for
therapeutic and recreational purposes since the beginning of recorded history. In particular alkaloids,
pharmacologically active cyclic nitrogen containing metabolites derived from amino acids, are known
for their pharmacological effects and frequently serve as the starting point for drug development [2].
Some of the oldest domesticated medicinal plants have been those that produce alkaloids. For example,
Erythroxylum coca, a species notable for the production of the tropane alkaloid cocaine (1), was used in
Peruvian households at least 8000 years ago [3]. Similarly, pomegranate (Punica granatum) has a history
of cultivation that goes back at least 10,000 years in Egypt and is well-known for the production of
granatane alkaloids [4].
Tropane (TA) and granatane (GA) alkaloids are structural homologues, sharing similar chemical
compositions and core scaffolds. Despite their similarities, TAs and GAs show different distribution
patterns across the plant kingdom. The N-methyl-8-azabicyclo[3.2.1]-octane core structure of TAs is
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found in over 200 alkaloids [2,5,6] (Figure 1). In contrast, N-methyl-9-azabicyclo[3.3.1]-nonane, the
core scaffold of GAs, appears in considerably fewer alkaloid metabolites (Figure 1). The bicyclic core
structures of TAs and GAs differ by only one carbon atom, yet this difference alters the conformational
preferences of each of the core skeletons [7]. Furthermore, the presence or absence of a single carbon
atom in the core rings of TAs and GAs alters their chemical and pharmacological activities.
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Figure 1. (a) The tropane core skeleton; (b) The bicyclic granatane core skeleton. Both structures depict 
their chemically accepted carbon numbering.  
1.1. Similarities and Differences in Medicinal Properties 
Despite their structural similarities TAs and GAs have distinct medicinal properties. TAs have 
been considered panaceas throughout recorded history, especially because of their anticholinergic 
properties. Anticholinergics are a class of compounds used as drugs to block the action of the acetylcholine 
neurotransmitter to treat motion sickness and diseases such as Alzheimer’s and Parkinson’s [8]. The 
methylated nitrogen in the core ring of cocaine (1) and other TAs serves as a structural analog of 
acetylcholine. TAs have been observed to attach to and inhibit muscarinic acetylcholine receptors [9]. 
TAs found in the Solanaceae are well known for both their anticholinergic and antispasmodic properties 
that affect the parasympathetic nervous system [10–12]. These plants have been used for pain relief, 
anesthesia, and as a treatment for drug addiction [10]. Daturae Flos, the dried flowers of Datura metel 
also known as “yangjinhua” in China, has been utilized and recorded in the Chinese Pharmacopoeia 
as an anesthetic and was prescribed to treat cough, asthma and convulsions [13]. Przewalkia tangutica is 
a rare medicinal solanaceous plant found in the Tibetan Plateau of China in which the roots, seeds and 
entire vegetative tissues are utilized [14]. P. tangutica contains several biologically active TAs including 
anisodamine (2), scopolamine (3) and atropine (the racemic mixture of hyoscyamine (4). The TAs present 
in P. tangutica are associated with many biological activities including analgesic, spasm modulation, 
pesticidal, and anti-inflammatory effects [14]. Hyoscyamus niger, also known as henbane, has been 
utilized in Chinese traditional therapy as well as in Tibetan medicine [15]. H. niger has been used as 
a sedative and sleep agent [16]. Hyoscyamine (4) and scopolamine (3) are the dominant TAs of  
H. niger and both metabolites can cross the blood-brain barrier to effect the central nervous system 
[17]. Scopolamine (3) has more potent pharmaceutical activity when compared to hyoscyamine (4) and 
exhibits relatively fewer side effects, however the scopolamine (3) content of solanaceous plants is 
usually much lower than the hyoscyamine (4) content [11]. Because of this, there is an ongoing effort 
to fully understand the biosynthesis of scopolamine (3) and other TAs within the Solanaceae (see 
Section 4). 
The narcotic properties of cocaine (1), a TA from the non-solanaceous genus Erythroxylum, can be 
attributed to unique modifications of the TA core scaffold that are not present in TAs from solanaceous 
plants. The carboxylic acid methyl ester present at the C2 position is responsible for the binding of 
cocaine (1) to the dopamine transporter [18]. Cocaine (1) has also been reported to block the reuptake 
of nor-epinephrine, serotonin (5-HT receptor) and dopamine (D-A receptor) by the binding of the 
aromatic ring present at the 3β position of the molecule to specific sites in these receptors, affecting the 
normal physiology of the central nervous system [19]. This stereospecific conformation is dominant in 
TAs found in the Erythroxylaceae, but is only a minor constituent in solanaceous plants. 
While no direct studies regarding the anticholinergic effects of GAs have been reported, a 
computational and NMR based study comparing the structures of TAs and GAs revealed that GAs 
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While no direct studies regarding the anticholinergic effects of GAs have been reported,
a computational and NMR based study comparing the structures of TAs and GAs revealed that
GAs adopt an N-axial form that is similar to many known TAs [20]. The N-methyl group in the axial
conformation is thought to be the pharmacophore for TAs [21]. Additionally, the granatane ring system
provides the semisynthetic intermediate for the potent antiemetic agents Dolasteron and Granisetron,
which are serotonin 5-HT3 receptor agonists [22,23]. These compounds are used as medicines to
prevent acute nausea in patients undergoing chemotherapy and radiotherapy for the treatment of
cancer [24].
GAs and TAs have different physiological effects beyond the central nervous system. Unlike TAs,
GAs exhibit anti-proliferative effects on hepatoma cells [24]. Specifically, murine hepatoma (BNL CL.2)
and human hepatoma (HepG2) cell lines were cultured with various doses of crude GA-containing
alkaloid fraction extracts from Sedum sarmentosum. Inhibition of excessive growth of tumor cells was
observed, indicating that these compounds possess anti-cancer properties [25]. Other physiological
effects that distinguish GAs from TAs include the use of GAs as an anti-worm treatment. Since the
isolation of the first GAs, these compounds have been claimed to possess anti-worm (anthelminthic)
capabilities, which were then studied in detail by scientists in the University of Amsterdam in
1956. These studies focused on deriving which GAs possessed the highest anthelminthic activity.
The anthelminthic activity of synthetic granatane and its derivatives were measured in liver fluke.
Their results rendered the highest anthelminthic activity to the compound isopelletierine [26].
These findings were later scientifically supported in 1963 with newer and better chemical methods [27].
Fascioliasis, a disease caused by liver fluke Fasciola hepatica, is common in cattle. Molluscidal activity in
pomegranate bark extracts was effective in killing of Lymnaea acuminata, the vector for F. hepatica [28,29].
Beyond their medicinal properties, GAs also differ from TAs in that GAs have been found to be useful
in the prevention of corrosion in the oil, gas and metal industries [30].
1.2. The Scattered Distribution of Tropanes and Granatanes amongst Angiosperms
Tropane alkaloids are commonly found in the genus Erythroxylum of the Erythroxylaceae family.
The Erythroxylum genus includes at least 230 species that are distributed throughout the tropical
regions of South and Central America [3,31,32]. Erythroxylum coca was one of the first domesticated
plant species that provided nutritional, medicinal, and digestive properties to ancient civilizations
by chewing the leaves of the plant [33]. Most of the cultivated coca used for cocaine (1) production
comes from this species [34]. Albert Neimann first isolated cocaine (1) as a pure substance in 1860 [35]
and its use exploded in popularity following an endorsement by Sigmund Freud [36]. The leaves
of Erythroxylum novogranatense were also chewed by the elite class for their high content of methyl
salicylate, which imparts a minty taste [37,38]. This species is known as “Colombian coca” and is
found to be cultivated in the mountains of present day Colombia. “Trujillo coca” (E. novogranatense
var. truxillense) is a cultivar that is grown in dry and arid regions. This species is also rich in methyl
salicylate and contains other flavoring qualities that are still used in the production of Coca Cola,
however today the extracts are decocainized [34].
Atropine, scopolamine (3), and hyoscyamine (4) are a few well-known TAs from the Solanaceae
family. As discussed above, these compounds are commonly found in species such as Atropa belladonna,
H. niger, and many members of the genus Datura. Scopolamine (3) was first isolated in 1888
from Scopolia japonica [39]. In medieval Europe, extracts from A. belladonna, were used as poisons,
hallucinogens and aphrodisiacs [17]. Five to ten berries of A. belladonna could kill a person. The toxicity
of the extracts has also been used on arrows to poison victims [40]. When extracts of A. belladonna are
applied to the eyes, dilation of the pupils occurs [41]. For this reason, women used A. belladonna as
a cosmetic drug during the Renaissance. Women of the 15th century who were devoted to witchcraft
also exploited the psychoactive effects of A. belladonna [16]. Mucous membranes, such as those found
in the walls of the oral cavity and the vulva, are readily susceptible to drug absorption. It is believed
that the application of alkaloid-containing salves to the skin or vulva was achieved by the use of
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brooms. It gave users the feeling of being able to fly, feeding the folkloric associations of witches
with brooms [17]. Atropine was first isolated in 1833 from A. belladonna [42,43]. The correct structure
of atropine was obtained by Willstätter in 1889 after much deliberation and structural studies [17].
Leaves of D. metel from solanaceous plants were used as herbal cigarettes in the 19th and 20th centuries
to treat patients with asthma or other respiratory conditions [17].
GAs include pelletierine (5), isopelletierine, pseudopelletierine (6), and N-methylpelletierine (7)
and their derivatives anabasine (8) and anaferine (9) (Figure 2). GAs are predominantly found in
P. granatum although they have been characterized in other species such as S. sarmentosum, and
Withania somnifera [44–47]. The pomegranate tree is native to Iran, Afghanistan, Baluchistan, and
Himalayas in Northern India. Pomegranate can also be found in the Mediterranean and Caucasus
regions due to its ancient cultivation. Today, pomegranate is cultivated all over India, Southeast Asia,
Malaysia, the East Indies, tropical Africa, and the United States [48]. In 1879, French chemists Tanret
and Pelletier isolated a basic substance from the root bark of the pomegranate tree and characterized
the salt [45]. As of this review, no studies regarding characterization of any structural genes or the
enzymes responsible for the production of GAs has been reported. Interestingly, the isolation of
pseudopelletierine (6) has been reported in the species Erythroxylum lucidum [49] suggesting that GAs
and TAs may use similar biosynthetic machinery.
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the Solanaceae and Erythoxylaceae are few. When viewed against a phylogeny of angiosperms, the 
results reveal a scattered and non-contiguous distribution (Figure 3) [50,51]. For example, TAs have 
been reported in members of the family Proteaceae. Compounds found in the family Proteaceae include 
the pyranotropanes, strobamine and bellendine as well as the compounds ferruginine and ferugine [52]. 
In addition, a few members within the families Brassicaceae and Convolvulaceae have been found to 
produce calystegines, which are heavily hydroxylated forms of TAs [53]. The main TA producing 
species are scattered among four orders, which include the Solanales, Malpighiales, Proteales and 
Brassicales. In the case of GAs, P. granatum from the family Lythraceae is the main producing species. 
However, the appearance of GAs has also been reported in members of the Solanaceae, Crassulaceae, 
and Erythroxylaceae families. These families belong to the orders Myrtales, Solanales, Malpighiales, 
and Saxifragales. This distribution pattern raises the important question about the biosynthetic origin of 
the respective GA and TA pathway. Namely, have these biosynthetic pathways arisen from a common 
ancestor or have they arisen independently in several cases? Recent evidence in TA biosynthesis 
suggests that certain biosynthetic steps have multiple origins [5]. By extension, this could also mean 
that GA biosynthesis has arisen independently more than once.  
Figure 2. Examples of granatane alkaloids and granatane alkaloid derivatives found among several
plant species.
Scientific reports on the occurrence and distribution of TAs from angiosperm families other than
the Solanaceae and Erythoxylaceae are few. When viewed against a phylogeny of angiosperms, the
results reveal a scattered and non-contiguous di tribution (Fig re 3) [50,51]. For example, TAs have
been reported in members of the family Proteaceae. Compounds found in the family Proteaceae
include the pyranotropanes, strobamine and bellendine as well as the compounds ferruginine and
ferugine [52]. In addition, a few members within the families Brassicaceae and Convolvulaceae have
been found to produce calystegines, which ar h avily hydroxylated forms of TAs [53]. The main TA
producing species are scattered among four orders, which include the Solanales, Malpighiales, Proteales
and Brassicales. In the case of GAs, P. granatum from the family Lythraceae is the main producing
species. However, the appearance of GAs has also been reported in members of the Solanaceae,
Crassulaceae, and Erythroxylacea families. These fam lie belong o the orders Myrtal s, Solanales,
Malpighiales, and Saxifragales. This distribution pattern raises the important question about the
biosynthetic origin of the respective GA and TA pathway. Namely, have these biosynthetic pathways
arisen from a common ancestor or have they arisen independently in several cases? Recent evidence in
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TA biosynthesis suggests that certain biosynthetic steps have multiple origins [5]. By extension, this
could also mean that GA biosynthesis has arisen independently more than once.Molecules 2016, 21, 1510 5 of 24 
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Examples of scattered distributions of alkaloid classes can be observed throughout the plant 
kingdom. For example, the legumes (Fabaceae) contain several alkaloid secondary metabolites that are 
not found in all members within the family [55]. In some cases, de novo evolution of the pathways have 
been observed. In the case of indolizidine alkaloids, the source of the scattered appearance of alkaloids 
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Figure 3. The diversity and similarities of tropane and granatane producing angiosperms. The orders
tropane alkaloids belong to are highlighted in orange. The orders granatane alkaloids belong to are
highlighted in blue. Shared orders are represented by both colors. The plant families that are known to
produce tropane and granatane alkaloids are branched off from the orders. The scale at the bottom
represents millions of years. Modification of the phylogenetic tree published in [54], republished with
permission with the Botanical Society of America.
Examples of scattered distributions of alkaloid classes can be observed throughout the plant
kingdom. For example, the legumes (Fabaceae) contain several alkaloid secondary metabolites that are
not found in all members within the family [55]. In some cases, de novo evolution of the pathways have
been observed. In the case of indolizidine alkaloids, the source of the scattered appearance of alkaloids
is theorized to occur due to horizontal gene transfer from alkaloid producing endophytic fungi.
1.3. Biosynthesis of TAs and GAs
Diversity among tropane and granatane alkaloids can also be seen at the biochemical level.
Most data available regarding enzymes involved in TA biosynthesis comes from species within
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the Solanaceae family. Despite recent advancements, some critical steps in TA biosynthesis remain
ambiguous. Additionally, recent advances in high throughput sequencing technologies, plant genomics,
and biochemical methods have aided the progress of elucidating TA biosynthesis in other non-model
species, specifically within the Erythroxylaceae. Lastly, even though the biosynthesis of GAs is
predicted to be similar to TAs, plausibly a whole new set of enzymes were recruited for the biosynthesis
of GAs. This would mean that untapped gene and enzyme diversity is present in the GA and TA
biosynthetic pathways. It is therefore important to elucidate the biosynthesis of these alkaloids to help
further understand specific parts of their mechanisms and their metabolic processes.
2. Tropane Alkaloid Biosynthesis
Overall, the process of producing either TAs or GAs in plants begins with the diversion of specific
amino acids from primary metabolism into the formation of an initial nitrogen-containing ringed
compound. This heterocycle will in most cases proceed on to form a bicyclic structure in which the
core skeletons are created (Figure 1). Further modifications will add diverse functional groups to the
core structure yielding the final end product. Ornithine (10) and arginine (11) are the amino acids
predicted to be the starting substrates of TA biosynthesis (Scheme 1) [56]. Feeding studies using
14C-proline into the roots of A. belladonna also suggest that proline (12) may be a starting amino acid for
incorporation into the tropane moiety. Other studies using D. metel and D. stramonium have also shown
the incorporation of proline (12) into TA compounds, such as scopolamine (3) and tropine (13) [57].
Biosynthetically each of these three amino acids can generate a pyrroline-5-carboxylate intermediate,
which can be interconvertible between these amino acids [58]. Consequently, feeding studies of labeled
amino acids are difficult to interpret without further enzymological data.
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Scheme 1. Tropane alkaloid biosynthesis up to the formation of the N-methyl-Δ1-pyrrolinium cation. 
Arginine, ornithine and proline are interconvertable, sharing the pyrroline-5-carboxylate intermediate 
(highlighted in blue). Putrescine can be formed directly via decarboxylation of ornithine or indirectly 
through arginine. Methylation of putrescine is followed by oxidation to yield 4-methylamino-butanal, 
which is then spontaneously cyclized to yield the N-methyl-Δ1-pyrrolinium cation. Enzymes are 
highlighted in orange and abbreviated as follows: ADC, arginine decarboxylase; AIH, agmatine imino 
hydrolase; NCPAH, N-carbamoylputrescine amino hydrolase; ODC, ornithine decarboxylase; PMT, 
putrescine N-methyl transferase; MPO, methyl putrescine oxidase. 
Scheme 1. Tropane alkaloid biosynthesis up to the formation of the N-methyl-∆1-pyrrolinium cation.
Arginine, ornithine and proline are interconvertable, sharing the pyrroline-5-carboxylate intermediate
(highlighted in blue). Putrescine can be formed directly via decarboxylation of ornithine or indirectly
through arginine. Methylation of putrescine is followed by oxidation to yield 4-methylamino-butanal,
which is then spontaneously cyclized to yield the N-methyl-∆1-pyrrolinium cation. Enzymes are
highlighted in orange and abbreviated as follows: ADC, arginine deca boxylase; AIH, agmatine imino
hydrolas ; NCPAH, N-carbamoylputrescine amino hydrolase; ODC, ornithine decarboxylase; PMT,
putrescine N-methyl transferase; MPO, methyl putrescine oxidase.
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A nonsymmetrical intermediate has been proposed for the production of the pyrrolidine ring,
if the amino acid ornithine (10) is first methylated at the γ-N position. A proposed alternative route
includes the decarboxylation of ornithine (10) to form the polyamine putrescine (14) as the first
step [59,60]. Feeding studies of radioactively labeled ornithine-2-14C have shown that several Datura
species incorporate a nonsymmetrical intermediate [59]. However, a symmetrical intermediate has
been reported for Nicotiana, Erythroxylum, and Hyoscyamus species [61]. Symmetrical incorporation
showed activity at positions C1 and C5 of the tropane ring and has been reported for Nicotiana, E. coca,
and Hyoscyamus albus [59,60]. A one-step enzymatic approach is possible to reach a symmetrical
intermediate by converting ornithine (10) into putrescine (14) catalyzed by ornithine decarboxylase
(ODC) [62]. Another route to putrescine (14) can be taken by starting with the amino acid arginine (11).
The decarboxylation of arginine (11) into agmatine (15) is catalyzed by arginine decarboxylase (ADC).
Agmatine (15) can then be converted into N-carbamoyl putrescine (16) via agmatine imino hydrolase
(AIH). The enzyme N-carbamoyl putrescine amido hydrolase (NCPAH) then yields putrescine (14).
Both the ADC and ODC directed pathways have different and diverse outcomes in regards to primary
and secondary metabolism. Putrescine (14) that was produced by ODC is important for the supply
of polyamines for primary metabolic processes such as cellular differentiation, development and
division [63]. On the other hand, putrescine (14) that was produced by ADC in the Solanaceae is
thought to be required for environmental stress related responses.
The formation of N-methylputrescine (17) catalyzed by putrescine N-methyltransferase (PMT)
is considered the first rate-limiting step in the TA biosynthetic pathway [64]. PMT is an
S-adenosylmethionine (SAM)-dependent methyltransferase that attaches a methyl group to the
nitrogen atom that ultimately appears in the tropane skeleton. The first PMT sequence to be isolated
from plants came from tobacco (Nicotiana tabacum) [65]. Since then, many other PMT related sequences
have been isolated and characterized from other pyrrolidine alkaloid producing plant species. PMT
belongs to a large family of enzymes that are involved in polyamine production. These primary
metabolites play an important role in stress physiology, senescence, and morphogenesis [66].
Several lines of evidence suggest that PMT function has evolved from an ancestral spermidine or
spermine synthases [67]. This would suggest that an enzyme from primary metabolism was recruited
for the production of secondary metabolites. Localization of the PMT protein is root specific for
both nicotine and tropane producing solanaceous plants [68–70]. While N-methylputrescine (17)
is the predominant intermediate for solanaceous TAs, at least one alternative has been suggested.
[6-14C]-1,5,10-triazadecane fed to Nicotiana glutinosa plants revealed that N-methylspermidine can also
be incorporated into the pyrrolidine ring of nicotine [71].
The next step in TA biosynthesis is the formation of 4-methylamino-butanal (18) from
N-methylputrescine (17) catalyzed by methylputrescine oxidase (MPO). This enzyme coexists with
a class of copper-dependent diamine oxidases that uses copper as a cofactor to oxidize a conserved
tyrosine residue into a topaquinone, essential for enzyme catalysis [72]. MPO was first characterized
from the species N. tabacum [73,74]. Although an MPO like gene has yet to be discovered in E. coca,
the corresponding activity from intact plants fed 4-monodeuterated N-methylputrescine shows the
same enantioselectivity as solanaceous plants that produce either nicotine or TAs [75]. Using 13C
fractionation techniques, researchers have found that both nicotine and hyoscyamine (4) share the
same biosynthetic pathway, at least up to the N-methyl-∆1-pyrrolinium cation (19) [76]. Subsequently,
a hypothesis has been proposed that a metabolic channel prevails in which a multi-enzyme complex
is active. The product of MPO, 4-methylamino-butanal (18), spontaneously cyclizes to form the
N-methyl-∆1-pyrrolinium cation (19) [59]. Feeding studies using ornithine-2-14C detected labeled
4-methylamino-butanal in D. stramonium plants [59]. The N-methyl-∆1-pyrrolinium cation (19) serves
as the first ring in the bicyclic tropane skeleton.
While the biochemical role of PMTs and MPOs are generally accepted steps leading to the first
ring closure of tropane intermediates in the Solanaceae, the enzymatic basis of the second ring closure
is controversial. For many years, the compound hygrine (20), (R)-1-(1-methylpyrrolidin-2-yl)-propan-
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2-one was thought to be a direct intermediate based on feeding studies, however more recent studies
have demonstrated that previous results are likely experimental artifacts [77–79]. In solanaceous
plants the best incorporation into the second ring was achieved from racemic ethyl [2,3-13C2]-
4-(N-methyl-2-pyrrolidinyl)-3-oxobutanoate [77,80], a polyketide based molecule (Scheme 2).
Further evidence for the involvement of a polyketide was demonstrated by the feeding of
methyl (RS)-[1,2-13C2,1-14C]-4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoate to the leaves of E. coca [81].
This strongly implicates the involvement of acetate-derived metabolites (e.g., polyketides) during the
formation of the second ring in TAs. There are limited types of enzymes capable of catalyzing this type
of condensation reaction. In the case of benzylisoquinoline alkaloid biosynthesis a Pictet–Spenglerase
enzyme was shown to condense dopamine with 3,4-dihydroxyphenylacetaldehyde [82]. However,
based on more recent isotope and radiolabeled feeding studies it is hypothesized that
a type III polyketide synthase (PKS) reaction is involved in condensing acetate units onto the
N-methyl-∆1-pyrrolinium cation (19) leading to the second ring closure of TA biosynthesis [77,80,83].
Type III PKSs are a family of enzymes known to catalyze the iterative decarboxylative condensation
of malonyl-CoA onto CoA-tethered substrates. Type III PKSs are promiscuous enzymes that have
a broad tolerance for diverse substrates and are able to catalyze multiple reactions [84,85]. Type III
PKSs that use cyclic nitrogen-containing substrates have been previously characterized for their roles
in alkaloid production [86–88]. However, unlike these previous studies the predicted substrate in TA
metabolism, N-methyl-∆1-pyrrolinium cation (19) is charged and lacks a CoA thioester.
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(S R) fa ily that catalyzes NAD(P)(H)-dependent monomeric oxidoreductase reactions [89].
Its activity controls the metabolic flux towards TA biosynthesis downstream [90]. In solanaceous
plants, two types of tropinone reductases exist, tropinone reductase I (TR I) and tropinone reductase
II (TR II). They share a common tertiary “Rossman” fold structure, a conserved motif that consists
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of two pairs of α-helices and six parallel β-sheets, a catalytic active site with the motif YxxxK, and
a dinucleotide cofactor-binding motif [91]. These enzymes share more than 50% of amino acid sequence
similarity and are also assumed to have evolved from a common ancestor [90]. As little as five amino
acid differences are needed to change the stereochemistry of the product [92]. TR I only converts
the 3-keto function to a product that has a 3α-configuration (Scheme 3). This produces tropine (13)
(3α-tropanol), which serves as a precursor for a wide range of esterified TAs [5]. On the contrary, TR II
produces an alcohol solely with a 3β-configuration called pseudotropine (3β-tropanol). This is then
converted to different nonesterified TAs called calystegines. A gene duplication event is attributed to
these two different TRs in the Solanaceae family [93].
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However in E. coca, a very different type of reductase enzyme was found for the reduction of
the 3-keto function of methylecgonone (21) (Scheme 4). This is the first evidence of a polyphyletic
origin for TA biosynthesis in plants. Methylecgonone reductase (MecgoR) was purified from crude
protein extracts from coca leaves using classical biochemical techniques [5]. This enzyme was found to
be very different than the TR enzymes that catalyzed the reduction reaction of the 3-keto function in
solanaceous plants. MecgoR shares an overall identity of less than 10% at the amino acid level
when compared to any TRs. MecgoR belongs to an aldo-keto reductase (AKR) superfamily of
enzymes. AKRs that have been characterized so far share a common α/β-barrel motif, using either
NADH or NADPH as a cofactor [94]. The MecgoR protein is localized in the palisade parenchyma of
young developing leaves. This is in contrast to the localization of roots in TRs of solanaceous plants.
This enzyme is also similar to other enzymes of alkaloid metabolism such as codeinone reductase and
an enzyme of flavonoid biosynthesis, chalcone reductase. The stereospecific enzyme MecgoR catalyzes
the conversion of methylecgonone (21) to the 3β-hydroxy-containing compound methylecgonine (22).
MecgoR can also use tropinone (23) as a substrate but this only produces pseudotropine, which
is consistent in E. coca with the presence of only 3β-hydroxy esters. Common TAs are esterified
with aromatic or aliphatic acids, with the stereochemistry of the hydroxyl group dependent on the
reductase used.
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The benzoic ester of methylecgonine (22) is cocaine (1). Methylecgonine (22) is a molecule that
has little physiological activity until it is converted into cocaine (1) [95]. There has been a prediction
that an acyltransferase in E. coca utilizes benzoyl-CoA as the activated acid. This prediction was
based on feeding studies using trans-[3-13C,14C]-cinnamic acid and the N-acetylcysteamine thioester
of [3-13C,14C]-trans-cinnamic acid [96]. Methylecgonine (22) undergoes esterification with a benzoyl
moiety that was predicted to utilize benzoyl-CoA as the activated acyl donor [97]. It was not
determined if it arises from benzoyl-CoA or benzaldehyde, but the moiety was found to be derived
from cinnamic acid [96,97]. Acylation reactions of secondary metabolites in plants are catalyzed
by several acyltransferase families, however only the BAHD acyltransferase is known to utilize
the activated acyl-CoA thioesters [98]. TAs are modified through the esterification of the hydroxyl
function at the C3 position in the tropane ring. It has been established that in E. coca, the cocaine
synthase reaction uses benzoyl-CoA and methylecgonine (22) as substrates. With the CoA-dependent
nature of this enzyme along with the reported properties for the tigloyl-CoA:pseudotropine
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acyltransferase from D. stramonium, it was hypothesized that cocaine synthase is a member of the
BAHD acyltransferase superfamily [99]. This superfamily of enzymes is well known to participate in
secondary metabolite modification of esters and amides [98]. Cocaine synthase was found to be capable
of producing both cocaine (1) via activated benzoyl-CoA thioester and cinnamoylcocaine via activated
cinnamoyl-CoA thioesters [100]. It has been determined that the acylation of the 3β-hydroxyl function
of methylecgonine (22), catalyzed by cocaine synthase, forms cocaine (1) and other TAs in E. coca.
The accumulation and biosynthesis of TAs in E. coca occur within the same tissue. Cocaine synthase
is found localized in the parenchyma and spongy mesophyll of the leaves. These tissues are both
responsible for the biosynthesis and storage of TAs in this species. 4-coumaroylquinate has been
reported to assist in the storage of cocaine (1) and cinnamoylcocaine in E. coca [101]. This is in contrast
to TAs produced in the Solanaceae family where the core biosynthetic pathway is in the roots, while
the metabolites accumulate in the aboveground portions of the plants [70].
The rearrangement of the hydroxyl group of the phenyllactic acid moiety of littorine (24) in TA side
chain biosynthesis has drawn interest. The phenomenon occurs in both atropine and scopolamine (3)
biosynthesis. A branched-chain residue, tropic acid, is formed from the linear chain phenyllactic
acid. To better understand this process, feeding studies of radiolabeled compounds have tried
to elucidate the mechanism of this reaction [102–106]. Feeding studies and quantum chemistry
calculations by Sandala et al. have led to the hypothesis that a cytochrome p450 coupled with an alcohol
dehydrogenase is involved in the conversion of the littorine (24) precursor into hyoscyamine (4) [107].
Li et al. were able to suppress cytochrome p450 CYP80F1 expression by using virus-induced gene
silencing techniques that caused reduced levels of hyoscyamine (4) and promoted the accumulation
of littorine (24) [108]. Using arylfluorinated analogues of (R)- and (S)-littorine, Nasomajai et al.
were able to determine that the CYP80F1 catalyzed hydroxylation occurs via a benzylic carbocation
intermediate [109]. Reversible 3′-acetoxylation of hyoscyamine (4) is thought to control the flux from
hyoscyamine (4) to scopolamine (3) [110].
Hyoscyamine (4) is converted into the epoxide scopolamine (3) via hyoscyamine 6β-hydroxylase
(H6H). This enzyme was shown to be a 2-oxoglutarate-dependent dioxygenase from purified
H. niger [111,112]. Hydroxylation at the C6 position of hyoscyamine (4) followed by the epoxidation of
anisodamine (2) (6β-hydroxy hyoscyamus) is catalyzed by H6H. The localization of this enzyme was
also determined to be exclusively in the pericycle of roots [113]. Some solanaceous species contain
acylations at the C6, C7 and C3 positions [110]. In a recent networking analysis study of the tropane
biosynthetic pathway in D. innoxia, an enzyme activity was theorized in which acylation at the C3
position with a tiglic acid occurs using a C6 acylated tropane as the substrate [110]. By extension,
Nguyen et al. have suggested that there are alternate C6-hydroxylating enzymes present with
specificities different from H6H that could use tropinone (23) as a substrate instead of the reduced
tropine (13) derivative. The same networking study revealed that high variability exists for the
acylated tropanes which directly contributes to their chemical diversity [110]. Interestingly, some of
the 3-hydroxyl acylating enzymes appear to not be stereospecific. Such enzymes could be useful for
expanding the biocatalytic tools available to those interested in metabolic engineering or synthetic
biology of tropane derivatives.
3. Granatane Alkaloid Biosynthesis
In this review, our definition of GAs includes piperideine derived compounds that incorporate
a pelletierine (5) or N-methylpelletierine (7) core structure. There has been some confusion among
scientists regarding the naming and configuration of pelletierine (5). Older reports sometimes use
the name isopelletierine incorrectly to refer to the compound [R-1-(2-piperidyl) propan-2-one], which
in reality corresponds to pelletierine (5). The name isopelletierine is the optically inactive racemate
of pelletierine (5) [114]. The correct chemical name for the compound N-methylpelletierine (7) is
1-[(2R)-1-methyl-2piperdinyl]-2-propanone. Pseudopelletierine (6), also referred to as granatanone,
contains a bicyclic core and can be referred to as [9-methyl-9-azabicyclo [1,3,3] nonan-3-one].
Molecules 2016, 21, 1510 12 of 25
Additionally, the presence of anabasine (8), in Nicotiana species would by extension mean that selected
members of the Solanaceae can be classified as granatane producing members. Furthermore, the
solanaceous species W. somifera produces anabasine (8), which could also be classified as a GA.
In addition, several Sedum species (family Crassulaceae) produce the compounds pelletierine (5),
N-methylpelletierine (7), and pseudopelletierine (6). All of the species discussed above are members
of the order Solanales and are more closely related to one another than they are to other granatane
producing angiosperms (Figure 3). This may suggest that, at least within this order of angiosperms, the
biosynthetic pathways leading to either tropanes or granatanes are commonly derived. The last time
members of the Solanales shared a common ancestor with granatane producing lines in the Myrtales is
approximately 120 million years ago. This is similar to the distance between the tropane producing
Erythroxylaceae and Solanaceae.
The only research studies performed with the aim to demonstrate the biochemical precursors of
GAs have been performed by feeding plants radiolabeled precursors. Table 1 provides a comprehensive
summary of feeding studies performed in granatane-producing species as of this review. The labeled
products were then subjected to analysis via chemical breakdown and modification. While these
studies were informative, they can also be misleading when attempting to interpret them through the
viewpoint of biochemical enzymes and mechanisms. The general consensus is that lysine (25) is the
starting substrate for the entry into granatane biosynthesis. In several cases, different forms of labeled
lysine were found incorporated into the core granatane structure [115–120].
Table 1. Summary of radiolabel feeding studies performed on granatane-producing species.
Species Studied Radiolabeled Compound Where Label Was Found Reference
Punica granatum 1-14C-acetate N-methyl isopelletierine [119]
Punica granatum 2-14C-lysine N-methyl isopelletierine [119]
Withania somnifera 2-14C-lysine anaferine [119]
Punica granatum [1-14C] acetate
Isopelletierine, N-methylisopelletierine, and
pseudopelletierine [118]
Withania somnifera [1-14C] acetate anaferine [118]
Punica granatum DL-[2-14C] lysine N-methylisopelletierine asymmetrically [118]
Withania somnifera DL-[2-14C] lysine Anaferine asymmetrically [118]
Punica granatum [N-methyl-14C, 814C] methylisopelletierine pseudopelletierine [118]
Withania somnifera [8-14C] isopelletierine anaferine [118]
Punica granatum [1,515C] cadaverine and [3H] cadaverine N-methylisopelletierine and pseudopelletierine nonrandomly [121]
Punica granatum [14C] methionine N-methylisopelletierine and pseudopelletierine [121]
Sedum sarmentosum Sodium [1,2,3,4-





DL-[6-14C] lysine, L-[4,5-8H2] lysine,
and D-[6-14C] lysine
Only L enantiomer of lysine was incorporated into
N-methylpelletierine. [115]
Nicotiana glauca DL-[6-
14C] lysine, L-[4,5-8H2] lysine,
and D-[6-14C] lysine
Only L enantiomer of lysine was incorporated into anabasine. [115]
Sedum sarmentosum [6-14C] lysine N-methylisopelletierine [120]
Sedum sarmentosum 6-14C-DL-lysine N-methylpelletierine asymmetrically [117]
Sedum sarmentosum 4,5-3H2,6-14C-DL-lysine N-methylpelletierine [117]
Over the course of studies regarding granatane and piperideine alkaloid biosynthesis, there has
been some controversy over the origin of the intermediates in the biosynthetic pathway. One of the
main questions that has repeatedly been tested is whether or not cadaverine (26) is present in the
pathway to form pelletierine (5) and other granatane derivatives. Several contradictory observations
have been made depending on the type of label of the compound fed to plants as well as which
species was used. The majority of the debate regarding the beginning intermediates arises when
older radiolabel feeding studies in the Sedum species are used as a reference. These studies report the
asymmetrical incorporation of the starting precursors into their respective alkaloids. However, other
studies performed on pomegranate report that a symmetrical intermediate (such as cadaverine (26))
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must exist [122]. Possible explanations for this problem could be that the members of the family
Crassulaceae (e.g., Sedum species) do not utilize the same enzymatic steps as other granatane producing
members such as those found in the family Lythraceae.
The three hypothesized biosynthetic pathways for the production of GAs will be referred to as
Hypothesis I, Hypothesis II, and Hypothesis III; their schematic representation is shown in Scheme 5.
Hypothesis I is based on the observation that P. granatum plants fed [1.5-14C] and [1.5-14C 3H2]
cadaverine yields incorporation of the labels into N-methylpelletierine (7) and pseudopelletierine (6) [121].
In this pathway, lysine (25) is first decarboxylated to form cadaverine (26) which would
subsequently be methylated to form N-methylcadaverine (27) [119]. N-methylcadaverine (27)
would then be oxidized to form 5-methylaminopentanal (28) promoting a spontaneous cyclization
to form the N-methyl-∆1-piperidinium cation (29). This product would then ultimately form
N-methylpelletierine (7) or be converted to the corresponding oxobutanoate by the decarboxylative
condensation of two malonyl-CoA which would then cyclize to form pseudopelletierine (6).
Feeding studies performed in Sedum species report that cadaverine (26) is not present as an intermediate,
giving rise to Hypothesis II. By feeding [1-14C] cadaverine, Leistner et al. (1990) have predicted that
there should be a lysine decarboxylase enzyme that also contains oxidase activity such that the only
cadaverine (26) intermediate that exists is always enzyme bound [122]. Therefore, according to this
hypothesis, lysine (25) is catalyzed in one enzyme or enzyme complex to produce 5-aminopentanal (30).
The 5-aminopentanal intermediate (30) would cyclize to form a ∆1-piperidinium cation (31), which can
then be methylated at the nitrogen atom to form the N-methyl-∆1-piperidinium cation (29) or remain
unmethylated and ultimately go on to form pelletierine (5).
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In all three hypotheses the origin of the N-methyl group is via labeled methionine [121].
The biochemical methyl donor for this incorporation would be S-adenosylmethionine (SAM).
Hypothesis III also involves an early asymmetrical intermediate. In this hypothesis, the first biosynthetic
step is the methylation of lysine (25) which occurs at the ε-N position producing ε-N-methyl-lysine (32).
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This compound would then be decarboxylated to form N-methylcadaverine (27) which would undergo
oxidation to form 5-methylaminopentanal (28), promoting a spontaneous cyclization to form the
N-methyl-∆1-piperidinium cation (29). As described in Hypothesis I, the N-methyl-∆1-piperidinium
cation (29) would ultimately form N-methylpelletierine (7) and pseudopelletierine (6).
Radioactive acetate is incorporated into GAs regardless of which species is fed [116–119]. As is
the case with tropane alkaloid biosynthesis, the enzymes involved in the extension and cyclization
reactions of granatanes includes a putative polyketide synthase. Plants readily convert acetate
into malonyl-CoA via the enzyme acetyl-CoA carboxylase [123]. A type III polyketide synthase
utilizing 2 units of malonyl-CoA and the N-methyl-∆1-piperidinium cation (29) would produce
4-(1-methyl-2-piperinidyl)-3-oxobutanoyl-CoA (33). The prediction of the presence of a type III
polyketide synthase in GA biosynthesis is supported by radiolabeling studies which fed ethyl
(R,S)-[2,3-13C2,3-14C-]-4-(l-methyl-2-pyrrolidinyl)-3-oxobutanoate to D. stramonium plants [77,80,83].
The oxobutanoyl compound may then have several fates; its conversion to pseudopelletierine (6) by
intermolecular interaction of the positively charged nitrogen and the carboxyl CoA, or its conversion
to N-methylpelletierine (7) or pelletierine (5) by losing the carboxyl as CO2. Bicyclic GA producing
species are similar to solanaceous plants producing tropanes, namely the loss of the carboxyl group
due to a lack of methyl ester protection. As mentioned earlier in this review, the protection of the
carboxyl group of oxobutanoate by methylation gives rise to the moiety responsible for the narcotic
effects of cocaine (1), which would explain why GAs do not exhibit narcotic effects [18].
The enzymes responsible for carrying out the biochemical reactions described above are based
on an extension of similar reactions carried out in tropane producing species. The decarboxylation
of lysine (25) described in Hypothesis I would be performed by a P. granatum lysine decarboxylase
(LDC). The presence of a lysine decarboxylase in the synthesis of anabasine (8) in Nicotiana species
has been studied by the incorporation of [15N]-lysine into anabasine (8) [124]. The methylation of
cadaverine (26) would be achieved with the help of a P. granatum cadaverine N-methyltransferase
(CMT). CMTs have not been isolated and characterized in other species, but this enzyme is
predicted to be related to putrescine N-methyltransferases (PMT) and spermidine synthases (SPDS).
PMT cDNA sequences have been found in Nicotiana species by the sequencing of large genomic
libraries [125,126]. The enzymes SPDS and PMT have been found to share substrate specificity, but PMT
is dependent of the decarboxylated S-adenosylmethionine (dcSAM) as a co-substrate. The oxidation of
N-methylcadaverine (27) in P. granatum and Sedum species could be performed with the aid of an enzyme
similar to the methylputrescine oxygenase (MPO) present in the biosynthesis of nicotine in N. tabacum.
While a copper dependent oxidase is used for tropane alkaloid biosynthesis, it is not possible to rule out
alternative enzymes such as polyamine oxidases that require FAD as a cofactor [127]. The methylation
of lysine (25) described in Hypothesis III would be performed by a lysine methyltransferase (LMT).
The responsible enzyme may be related to the lysine methyltransferases ubiquitously present in
eukaryotic primary metabolism for gene access regulation to chromatin [128].
In both granatane and tropane alkaloid producing species, dimerized versions of intermediates
within their respective pathways have been found. For example, cuscohygrine is the dimerized form
of hygrine (20) [129]. Originally it was believed that hygrine (20) was a true intermediate of the
biosynthesis of TAs. However, it is most likely that cuscohygrine is a dimerized product of hygrine (20)
which in turn is a breakdown product of 4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoyl-CoA (34).
If this compound is present as a free acid under physiological conditions a β-ketoester is formed,
β-ketoesters very often spontaneously decarboxylate [130]. In the case of GA biosynthesis,
anaferine (9) is the dimerization product of pelletierine (5). This also supports the presence of
an oxobutanoate intermediate.
4. Metabolic Engineering
There has been an increasing interest in the biosynthesis of tropane alkaloids (TAs), especially to
up-regulate the production of valued compounds, such as atropine and scopolamine (3). The World
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Health Organization (WHO) includes these important pharmaceutical compounds on their list of
essential drugs [131]. In normal plant biosynthesis, the yields of the final compounds are in low
quantities. Synthesizing TAs chemically in the lab has also been difficult and costly because of their
stereochemical nature. Nocquet et al. attempted a total synthesis approach to produce the compound
scopolamine (3), however their low yield of 16% does not make this method economically feasible [2].
A major problem for the commercial production of scopolamine (3) in hairy root cultures is achieving
industrial level yields [132]. Researchers are now focused on metabolic engineering plants that produce
these important compounds to increase final yields, or engineering microorganisms that will be able to
produce the compounds from simple sugars or common precursors. A comprehensive table of the
most recent metabolic engineering studies targeting specific genes can be seen on Table 2.
Table 2. A summary of recent metabolic engineering studies targeting specific genes.
Species Target Compound Gene/Genes Modified Effect Reference
Atropa belladonna Scopolamine NtPMT & HnH6H Increased scopolamine content [11]
Atropa belladonna Hyoscyamine & scopolamine rolC, pmt, & h6h Increased hyoscyamine content &increased scopolamine content [133]
Escherichia coli Putrescine Multiple Increased putrescine production [134]
Brugmansia condida Polyamines (putrescine) rolC Polyamine accumulation,improve hairy root growth [135]
Atropa belladonna Pseudotropine/Tropine tr-1/tr-2 Higher enzyme activity & increasein pseudotropine/tropine [136]
Anisodus acutangulus TAs pmt & tr-1 Increased TA levels withhyoscyamine being major alkaloid [137]
Due to its high demand in medicine, scopolamine (3) is the most popular choice for increasing
yields via metabolic engineering. Past methods such as genetic breeding, polyploid breeding and
radiation breeding have failed to yield a higher content of scopolamine (3) in A. belladonna [138].
Researchers are now focused on the genes encoding rate-limiting enzymes in TA biosynthesis that
can be genetically modified in planta. A common focal point centers on what is considered the
first and last rate-limiting enzymes in the TA pathway, putrescine N-methyltransferase (PMT) and
hyoscyamine 6β-hydroxylase (H6H). The overexpression of only one PMT gene in transgenic hairy
root cultures of A. belladonna did not change the total TA content [139]. If the same PMT gene in
D. metel was overexpressed, the TA content was significantly increased by almost four times that of the
control [140]. H6H has a high catalytic efficiency for converting hyoscyamine (4) to scopolamine (3) [141].
The overexpression of the H6H gene resulted in an increase in the biosynthesis of scopolamine (3) in
the transformed TA producing plant, A. belladonna. Another successful use of H6H was in transgenic
Hyoscyamus muticus hairy root cultures, where scopolamine (3) levels increased to over 100 times that
of the controls [142]. Furthermore, overexpression of H6H in transgenic A. belladonna plants resulted in
the leaf and stem alkaloid contents to be exclusively scopolamine (3) [141].
Metabolic engineering endeavors are becoming more complex and are moving away from only
modifying one gene at a time. When both PMT and H6H were overexpressed simultaneously in
transgenic H. niger root cultures, scopolamine (3) biosynthesis increased to levels over nine times
more than the wild type [143]. In an important experiment testing whether metabolic engineering
can occur between genes isolated from different species, overexpression of NtPMT and HnH6H in
A. belladonna significantly increased scopolamine (3) content of secondary roots when compared to
wild-type plants [11]. More studies are needed to understand flux through the tropane biosynthetic
pathway in order to increase the overproduction of alkaloids.
D. metel produces important medicinal tropanes and is used by researchers because of its tractable
hairy root culture system. Agrobacterium rhizogenes can transform plant roots to hairy roots by utilizing
the Ri T-DNA plasmid it carries. Hairy roots that have been induced by A. rhizogenes have high
growth rates, are genetically stable, and produce copious amounts of lateral roots [144]. Increased TA
biosynthesis correlated with an increase in root biomass. Biotic elicitors, such as yeast extract, bacteria,
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fungi and viruses, as well as abiotic elicitors, such as metal ions or inorganic components, are used
and studied to increase the productivity of hairy roots. These elicitors can trigger different defense
responses and phytoalexins in plants as well as improve the release of metabolites into the medium [10].
Shakeran et al. focused on using Staphylococcus aureus and Bacillus cereus as biotic elicitors and
silver nitrate and nanosilver as abiotic elicitors on the hairy root cultures of D. metel to see their
effects on biomass and atropine production. When live bacteria are present in transformed root
cultures, there is a considerable influence on secondary metabolite accumulation [145]. Contrary to
this, atropine content in the hairy roots of D. metel infected by B. cereus and S. aureus was reduced
more than half when compared to the control. The authors hypothesize that this may be a cause
of atropine secretion into the culture medium that was then converted into scopolamine (3) [10].
However, scopolamine (3) was not analyzed in the spent media. The living bacteria can cause various
influences on roots, affecting enzymes in the TA pathway to produce alkaloids in D. metel roots [145].
Although atropine accumulation decreased with these biotic elicitors, the biomass of the roots slightly
increased approximately 15% when compared to the control [10].
Other attempts to engineer higher TA contents in plants include those that use abiotic
elicitors. A summary of recent metabolic engineering studies using elicitors can be seen on Table 3.
Silver nitrate can increase anisodamine (2) content in Anisodus acutangulus hairy root cultures [146].
In addition, calcium and nitrate can increase hyoscyamine (4) content in D. stramonium hairy root
cultures [147]. Silver nitrate can inhibit the activation of ethylene and in doing so, promotes polyamine
synthesis [148,149]. As a consequence, the overall effect of silver nitrate treatment can be seen in the
increase of root biomass [148–150]. Furthermore, silver nitrate has been demonstrated to elicit the
production of phytoalexins which in turn increases TA levels in the root [151].
Shakeran et al. (2015) used silver nitrate as an abiotic elicitor in D. metel and observed an increase in
the transformed hairy root biomass of approximately 16%. However, only half of the expected atropine
accumulation was observed in these treatments. Although secretion of atropine was not measured in
this study, subsequent reports corroborated this hypothesis by finding a three-fold increase in alkaloids
in the spent culture media following silver nitrate treatment [152]. Still, further attempts at increasing
alkaloid levels include the treatment using nanosilver particles. These differ from silver nitrate in their
physicochemical properties [153,154]. Nanosilver particles adhere strongly to plant tissues and cause
an increase in the activation of enzymes involved in secondary metabolite production. This treatment
was used successfully in Artemisia annua and D. metel hairy roots increasing tropanes by at least
2.4 fold [10]. Initial polyamine substrates such as putrescine (14) must be present in abundance during
TA production for a high yield of the final alkaloid. Currently there are only a few studies attempting
to engineer the TA pathway in microorganisms. Qian et al. engineered a strain of Escherichia coli
capable of efficiently producing putrescine (14) [134]. However, it was first necessary to reduce the
flux of polyamine precursors through a competing pathway. Metabolic pathways for putrescine (14)
degradation, uptake and utilization were also deleted. Stress to cells by the overproduction of
putrescine (14) was handled by the deletion of RpoS, a stress responsive RNA polymerase sigma
factor. To increase the conversion of ornithine (10) to putrescine (14), overexpression of ornithine
biosynthetic enzymes and ornithine decarboxylase (ODC) was also necessary. The final metabolically
engineered E. coli strain produced 1.68 g/L of putrescine (14) and high cell density cultures (HCDCs)
produced 24.2 g/L of putrescine (14). This would be the first step for engineering alkaloid biosynthesis
that relies on putrescine (14) in microorganisms. In a follow-up study, Qian et al. (2011) performed
similar manipulations to produce a strain of E. coli capable of producing the polyamine cadaverine (26).
Introduction of an L-lysine decarboxylase in addition to overexpressing dapA, the gene encoding the
enzyme dihydrodipicolinate synthase successfully resulted in the new strain producing as much as
9.61 g/L cadaverine (26) from renewable resources [155]. If metabolic engineers in the future wish
to engineer these pathways in other organisms, such as bacteria or yeast, it will be necessary to
up-regulate the beginning precursor pathways such that pools of these primary metabolites do not get
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depleted. Depletion of these essential metabolites would result in the death of the organism during the
biosynthesis of these compounds.
Table 3. A summary of recent metabolic engineering studies using elicitors.
Species Target Compound Elicitor Effect Reference
Anisodus luridus Scopolamine Acetylsalicylic acid (ASA) Increased scopolamine content [156]
Anisodus luridus Scopolamine Ultraviolet ray-B (UV-B) Increased scopolamine content [156]
Datura metel Atropine Staphylococcus aureus Decreased atropine content, increased root biomass [10]
Datura metel Atropine Bacillus cereus Decreased atropine content, increased root biomass [10]
Datura metel Atropine Silver nitrate Decreased atropine content, increased root biomass [10]
Datura metel Atropine Nanosilver Increased atropine content, increased root biomass [10]
Datura innoxia Hyoscyamine Agrobacterium rhizogenes Increased hyoscyamine content, increased root biomass [110]
Erythroxylum coca Cocaine Anderson rhododendronmedium (ARM) Increased cocaine content in calli [157]
Erythroxylum coca Chlorogenic acid (CGA) Salicylic acid Decreased CGA content [157]
Using plant in vitro cell culture or tissue culture is an important tool when studying the regulation
and biosynthesis of secondary metabolites. Large quantities of plant material can be produced under
controlled and sterile conditions. In tissue cultures of solanaceous plant species, using elicitors
mimicking stress hormones can increase important secondary metabolite production [158]. Recently,
cell cultures of E. coca in the Erythroxylaceae were used to study TA biosynthesis [157]. Various culture
media were tested on their ability to support callus formation as well as cocaine (1) production.
The jasmonic acid-isoleucine (JA-Ile) analogue coronalon and salicylic acid (SA) were also used as
elicitors to observed their effects on calli metabolism. All three culture media growing calli accumulated
cocaine (1). The medium used to grow calli also significantly affected natural product metabolism.
The only treatments that yielded higher amounts of cocaine (1) were dependent upon culture media,
not upon elicitor treatment. For example, Anderson rhododendron medium (ARM) produced cocaine
(1) an order of a magnitude greater than both Gamborg B5 (GB5) and modified Murashige-Tucker
medium (MMT), but lower levels of hydroxycinnamate-quinate esters such as chlorogenic acid (CGA)
were detected. Interestingly the elicitors coronalon and salicylic acid did not yield any increase
in TA production suggesting that TAs, at least in E. coca, may not be regulated by common plant
defense hormones.
5. Conclusions
Recent advances in genomics, transcriptomic and metabolomic technologies are poised to
illuminate the biosynthetic foundations of TAs and GAs. Future research on the biosynthesis of
TAs and GAs will affect multiple fields of research. First, enzymes involved in TA and GA biosynthesis
will expand our fundamental knowledge of chemistry and enzymology. Second, elucidation of the
genes and enzymes underlying TA and GA biosynthesis will expand the molecular tools available to
synthetic biologists. With these additional tools, scientists can look to not only produce TAs and GAs in
heterologous hosts but also to engineer novel molecules [159]. Lastly, future discoveries of the function
and structure of genes and enzymes in TA and GA biosynthesis will strengthen our understanding of
the evolution of plant metabolism. Plant metabolism, especially specialized metabolites such as TAs
and GAs, evolved in response to dynamic environments. Detailed knowledge of the catalytic properties
of TA and GA biosynthetic enzymes as well as their biophysical properties are critical to our knowledge
of the evolution of biochemical activities and the chemical diversity of these metabolic pathways.
This fundamental knowledge will be useful in predicting and engineering plants to withstand ongoing
changes in the environment.
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